Physician profile
Jesse L Vanle
NPI 1366435224
$3,057.14
in general payments reported to CMS, 2019-2025
10 companies · $247 in 2025
The $247 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.12 · 2020: $61.97 · 2021: $469 · 2022: $145 · 2023: $264 · 2024: $1,842 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,268 · Travel and Lodging: $1,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,267.82 |
| Travel and Lodging | $1,084.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,094.11 | 2020-2024 | Indigo System |
| Medtronic, INC. | $693.47 | 2021-2025 | Hawkone, Concertotm, Abre |
| Zimmer Biomet Holdings, INC. | $453.67 | 2021-2025 | Venapax |
| W. L. Gore & Associates, INC. | $294.70 | 2023-2025 | Gore Tag Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Aaa Endoprosthesis |
| Inari Medical, INC. | $168.90 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $128.90 | 2021-2023 | |
| Organogenesis INC. | $82.35 | 2024 | |
| Medtronic Vascular, INC. | $81.54 | 2019-2020 | |
| Edwards Lifesciences Corporation | $42.05 | 2023 | Hemosphere |
| Boston Scientific Corporation | $17.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Vanle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.